These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 37832478)
1. The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterations. Luo D; Shi CY; Wei NS; Yang BY; Qin K; Liu G; Dong BQ; Qin YX; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Li H; Li J Tuberculosis (Edinb); 2023 Dec; 143():102413. PubMed ID: 37832478 [TBL] [Abstract][Full Text] [Related]
2. Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis. Huang Y; Tang JH; Cai Z; Qi Y; Jiang S; Ma TT; Yue Y; Huang F; Yang H; Ma YY Tuberculosis (Edinb); 2022 Sep; 136():102231. PubMed ID: 35964506 [TBL] [Abstract][Full Text] [Related]
3. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis. Zhou Y; Zhang F; Shi H; Wu P; Zhou Y Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397 [TBL] [Abstract][Full Text] [Related]
4. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status. Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942 [TBL] [Abstract][Full Text] [Related]
5. Alterations in the intestinal microbiota associated with active tuberculosis and latent tuberculosis infection. Huang Y; Tang J; Cai Z; Qi Y; Jiang S; Ma T; Yue Y; Huang F; Yang H; Ma Y Heliyon; 2023 Nov; 9(11):e22124. PubMed ID: 38045157 [TBL] [Abstract][Full Text] [Related]
6. Activation Phenotype of Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z Front Immunol; 2021; 12():721013. PubMed ID: 34512645 [TBL] [Abstract][Full Text] [Related]
7. Combination of HLA-DR on Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z Front Immunol; 2021; 12():761209. PubMed ID: 34858413 [TBL] [Abstract][Full Text] [Related]
8. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype. Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785 [TBL] [Abstract][Full Text] [Related]
9. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study. Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371 [TBL] [Abstract][Full Text] [Related]
10. Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis. Ma S; Peng P; Duan Z; Fan Y; Li X J Immunol Res; 2023; 2023():7829286. PubMed ID: 37228444 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100 [TBL] [Abstract][Full Text] [Related]
12. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study. Zhang L; Wan S; Zhou Z; Zhang Y; Liu X BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667 [TBL] [Abstract][Full Text] [Related]
13. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation. Sun Q; Wei W; Sha W PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330 [TBL] [Abstract][Full Text] [Related]
14. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection. Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795 [TBL] [Abstract][Full Text] [Related]
15. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection. Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954 [TBL] [Abstract][Full Text] [Related]
16. A Systematic Review on Novel Meier NR; Jacobsen M; Ottenhoff THM; Ritz N Front Immunol; 2018; 9():2476. PubMed ID: 30473692 [No Abstract] [Full Text] [Related]
17. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection. Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824 [TBL] [Abstract][Full Text] [Related]
19. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection. Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729 [TBL] [Abstract][Full Text] [Related]
20. Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection. Xi X; Wang B; Zhang R; Ling C J Microbiol Methods; 2024 Jul; 222():106944. PubMed ID: 38705210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]